Clinical trials
Completed Observational Primary Myelofibrosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 5 |
| 2008 | 2 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 30 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Icahn School of Medicine at Mount Sinai | 3 |
| City of Hope Medical Center | 2 |
| FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS | 2 |
| Fondazione IRCCS Policlinico San Matteo di Pavia | 2 |
| National Human Genome Research Institute (NHGRI) | 2 |
| Novartis Pharmaceuticals | 2 |
| University of Utah | 2 |
| AbbVie | 1 |
| Bristol-Myers Squibb | 1 |
| Case Comprehensive Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Primary Myelofibrosis | 30 |
| Myeloproliferative Disorders | 13 |
| Thrombocythemia, Essential | 11 |
| Polycythemia Vera | 10 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 6 |
| Leukemia, Myeloid, Accelerated Phase | 6 |
| Leukemia, Myeloid, Chronic-Phase | 6 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 6 |
| Blast Crisis | 5 |
| Burkitt Lymphoma | 5 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.